Related Experiment Videos
von Willebrand factor, endothelial cell damage and atherosclerosis
1Department of Surgery, University Hospital of South Manchester, Didsbury, U.K.
European Journal of Vascular Surgery
|January 1, 1994
Summary
High levels of von Willebrand factor (vWf) may indicate endothelial injury and predict cardiovascular events. Research into therapies reducing vWf could impact atherosclerosis progression.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Hematology
Background:
- von Willebrand factor (vWf) is an endothelial cell product with crucial roles in hemostasis.
- Elevated vWf levels are increasingly recognized in various vascular conditions.
Purpose of the Study:
- To explore the potential of plasma vWf levels as a marker for endothelial injury.
- To investigate the association between vWf and the pathogenesis and progression of atherosclerosis.
Main Methods:
- Observational studies comparing vWf levels in patients with atherosclerotic vascular disease and risk factors versus controls.
- Analysis of the correlation between high vWf plasma levels and adverse clinical outcomes.
Main Results:
- Increased vWf levels are observed in patients with atherosclerotic vascular disease and major risk factors (smoking, hypercholesterolemia, hypertension, obesity, diabetes).
- High plasma vWf is linked to predicting adverse events like myocardial infarction and poor outcomes after arterial surgery.
Conclusions:
- Plasma vWf levels show potential as a biomarker for endothelial injury.
- Therapeutic strategies targeting vWf reduction may be beneficial in managing arterial disease progression.